Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy
(Q34743875)
scientific article published on December 1, 1997
scientific article published on December 1, 1997
Language: